Alcon Receivables 2019-2025 | ALC

Alcon receivables for the quarter ending March 31, 2025 were $1.857B, a 1.14% increase year-over-year.

  • Alcon receivables for 2024 were $1.759B, a 2.49% decline from 2023.
  • Alcon receivables for 2023 were $1.804B, a 7% increase from 2022.
  • Alcon receivables for 2022 were $1.686B, a 12.03% increase from 2021.

Alcon Receivables 2019-2025 | ALC

  • Alcon receivables for 2024 were $1.759B, a 2.49% decline from 2023.
  • Alcon receivables for 2023 were $1.804B, a 7% increase from 2022.
  • Alcon receivables for 2022 were $1.686B, a 12.03% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$180.6B
Intuitive Surgical (ISRG)$177.8B
Edwards Lifesciences (EW)$46.9B
IDEXX Laboratories (IDXX)$45.5B
DexCom (DXCM)$34.9B
IQVIA Holdings (IQV)$33.9B
Mettler-Toledo (MTD)$26.3B
STERIS (STE)$22.7B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.5B
Hologic (HOLX)$14.8B
Sysmex ADR (SSMXY)$10.7B
Penumbra (PEN)$9B
Masimo (MASI)$8.9B
Globus Medical (GMED)$7.4B
Glaukos (GKOS)$5.4B
Teleflex (TFX)$5.2B
Integer Holdings (ITGR)$3.8B
TransMedics (TMDX)$3.7B
PROCEPT BioRobotics (PRCT)$3.1B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2.1B
Elekta AB (EKTAY)$2B
Veracyte (VCYT)$2B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Tandem Diabetes Care (TNDM)$1.1B
Integra LifeSciences Holdings (IART)$1B